Structure–Activity Relationship and Cytotoxic Evaluation of Benzimidazole Derivatives as Potential Antileukemic Agents
Comparative evaluation with standard drugs demonstrated that while doxorubicin exhibited higher potency, benzimidazole derivatives offered better selectivity and broader applicability compared to imatinib, underscore the potential of benzimidazole derivatives as lead scaffolds for the development of novel antileukemic agents.